𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Do hENT1 and RRM1 predict the clinical benefit of gemcitabine in pancreatic cancer?

✍ Scribed by Jordheim, Lars Petter; Dumontet, Charles


Book ID
125423278
Publisher
Future Medicine
Year
2013
Tongue
English
Weight
679 KB
Volume
7
Category
Article
ISSN
1752-0363

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Prognostic roles of human equilibrative
✍ Richard Kim; Ann Tan; Kevin K. Lai; John Jiang; Yixen Wang; Lisa A. Rybicki; Xiu πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 238 KB

## Abstract ## BACKGROUND: Pancreatic adenocarcinoma is a malignancy with a dismal prognosis. Previous studies have suggested that in pancreatic cancer, human equilibrative nucleoside transporter 1 (__hENT__‐__1__) and ribonucleoside reductase subunit M1 (__RRM1__) expression may have prognostic v